PortfoliosLab logo
LABD vs. IBBQ
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between LABD and IBBQ is 0.61, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.0
Correlation: 0.6

Performance

LABD vs. IBBQ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Direxion Daily S&P Biotech Bear 3x Shares (LABD) and Invesco Nasdaq Biotechnology ETF (IBBQ). The values are adjusted to include any dividend payments, if applicable.

-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2025FebruaryMarchApril
-50.59%
-16.50%
LABD
IBBQ

Key characteristics

Sharpe Ratio

LABD:

-0.12

IBBQ:

0.00

Sortino Ratio

LABD:

0.42

IBBQ:

0.15

Omega Ratio

LABD:

1.05

IBBQ:

1.02

Calmar Ratio

LABD:

-0.09

IBBQ:

0.00

Martin Ratio

LABD:

-0.25

IBBQ:

0.01

Ulcer Index

LABD:

37.29%

IBBQ:

7.77%

Daily Std Dev

LABD:

81.07%

IBBQ:

20.79%

Max Drawdown

LABD:

-99.97%

IBBQ:

-37.94%

Current Drawdown

LABD:

-99.95%

IBBQ:

-22.36%

Returns By Period

In the year-to-date period, LABD achieves a 20.91% return, which is significantly higher than IBBQ's -4.01% return.


LABD

YTD

20.91%

1M

5.58%

6M

45.11%

1Y

-17.25%

5Y*

-40.20%

10Y*

N/A

IBBQ

YTD

-4.01%

1M

-4.85%

6M

-11.77%

1Y

1.56%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


LABD vs. IBBQ - Expense Ratio Comparison

LABD has a 1.06% expense ratio, which is higher than IBBQ's 0.00% expense ratio.


Expense ratio chart for LABD: current value is 1.06%, compared with the broader market range of 0.00% to 2.12%.0.50%1.00%1.50%2.00%
LABD: 1.06%
Expense ratio chart for IBBQ: current value is 0.00%, compared with the broader market range of 0.00% to 2.12%.0.50%1.00%1.50%2.00%
IBBQ: 0.00%

Risk-Adjusted Performance

LABD vs. IBBQ — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LABD
The Risk-Adjusted Performance Rank of LABD is 2121
Overall Rank
The Sharpe Ratio Rank of LABD is 1414
Sharpe Ratio Rank
The Sortino Ratio Rank of LABD is 3434
Sortino Ratio Rank
The Omega Ratio Rank of LABD is 2929
Omega Ratio Rank
The Calmar Ratio Rank of LABD is 1313
Calmar Ratio Rank
The Martin Ratio Rank of LABD is 1515
Martin Ratio Rank

IBBQ
The Risk-Adjusted Performance Rank of IBBQ is 1919
Overall Rank
The Sharpe Ratio Rank of IBBQ is 2020
Sharpe Ratio Rank
The Sortino Ratio Rank of IBBQ is 1919
Sortino Ratio Rank
The Omega Ratio Rank of IBBQ is 1919
Omega Ratio Rank
The Calmar Ratio Rank of IBBQ is 2020
Calmar Ratio Rank
The Martin Ratio Rank of IBBQ is 1919
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

LABD vs. IBBQ - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily S&P Biotech Bear 3x Shares (LABD) and Invesco Nasdaq Biotechnology ETF (IBBQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for LABD, currently valued at -0.12, compared to the broader market-1.000.001.002.003.004.00
LABD: -0.12
IBBQ: 0.00
The chart of Sortino ratio for LABD, currently valued at 0.42, compared to the broader market-2.000.002.004.006.008.00
LABD: 0.42
IBBQ: 0.15
The chart of Omega ratio for LABD, currently valued at 1.05, compared to the broader market0.501.001.502.002.50
LABD: 1.05
IBBQ: 1.02
The chart of Calmar ratio for LABD, currently valued at -0.10, compared to the broader market0.002.004.006.008.0010.0012.00
LABD: -0.10
IBBQ: 0.00
The chart of Martin ratio for LABD, currently valued at -0.25, compared to the broader market0.0020.0040.0060.00
LABD: -0.25
IBBQ: 0.01

The current LABD Sharpe Ratio is -0.12, which is lower than the IBBQ Sharpe Ratio of 0.00. The chart below compares the historical Sharpe Ratios of LABD and IBBQ, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.50-1.00-0.500.000.501.001.502.00NovemberDecember2025FebruaryMarchApril
-0.12
0.00
LABD
IBBQ

Dividends

LABD vs. IBBQ - Dividend Comparison

LABD's dividend yield for the trailing twelve months is around 3.77%, more than IBBQ's 1.17% yield.


TTM2024202320222021202020192018
LABD
Direxion Daily S&P Biotech Bear 3x Shares
3.77%4.68%6.14%0.53%0.00%3.96%1.75%0.80%
IBBQ
Invesco Nasdaq Biotechnology ETF
1.17%1.14%0.81%0.76%0.62%0.00%0.00%0.00%

Drawdowns

LABD vs. IBBQ - Drawdown Comparison

The maximum LABD drawdown since its inception was -99.97%, which is greater than IBBQ's maximum drawdown of -37.94%. Use the drawdown chart below to compare losses from any high point for LABD and IBBQ. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2025FebruaryMarchApril
-88.22%
-22.36%
LABD
IBBQ

Volatility

LABD vs. IBBQ - Volatility Comparison

Direxion Daily S&P Biotech Bear 3x Shares (LABD) has a higher volatility of 45.61% compared to Invesco Nasdaq Biotechnology ETF (IBBQ) at 11.96%. This indicates that LABD's price experiences larger fluctuations and is considered to be riskier than IBBQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%NovemberDecember2025FebruaryMarchApril
45.61%
11.96%
LABD
IBBQ